Full Text View
Tabular View
Study Results
Related Studies
Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
This study has been completed.
Study NCT00488345   Information provided by Wyeth is now a wholly owned subsidiary of Pfizer

First Received on June 18, 2007.   Last Updated on September 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bacterial Infections
Intra-Abdominal Infection
Pneumonia, Bacterial
Skin Diseases, Bacterial
Skin Diseases, Infectious
Additional conditions recognized in this trial
Communicable Diseases
Infection
Pneumonia
Skin Diseases
More general conditions related to this trial
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Interventions listed in this trial
Tygacil
Additional drug interventions recognized in this trial
Tigecycline
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Wyeth is now a wholly owned subsidiary of Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services